When was Life Biosciences founded?

Life Biosciences was founded in 2017 and raised its 1st funding round within a year of its incorporation.

Where is Life Biosciences located?

Life Biosciences is headquartered in Boston, United States.

Who is the current CEO of Life Biosciences?

Jerry McLaughlin of Life Biosciences.

How many employees does Life Biosciences have?

As of Mar 01, 2026, the latest employee count at Life Biosciences is 10 - 49.

Is Life Biosciences a funded company?

Life Biosciences is a funded company, having raised a total of $261M across 9 funding rounds to date. The company's 1st funding round was a $***** Grant (prize money) round, raised on Jan 01, 2017.

When was the latest funding round of Life Biosciences?

Life Biosciences' latest funding was a $***** Series D round on Apr 08, 2026, with participation from 0 investor. Its primary sector is Geriatrics. In United States, the Geriatrics sector has seen $82M in funding in 2026 to date.

Where does Life Biosciences rank among its competitors?

Life Biosciences ranks 1st amongst 10 active competitors, of which 5 are funded. It stands 1st in terms of total funding among its competitors. The most recent competitor to raise funding was Life Biosciences, which secured $80M in Apr, 2026.

Who are the top competitors of Life Biosciences?

Life Biosciences' top competitors include Retro, Cambrian BioPharma and Rejuveron Life Sciences. Among them, Life Biosciences secured the most recent funding round in April, 2026.

Life Biosciences - 2026 Company Profile, Team, Funding & Competitors

Company Details

Biotechnology pioneering cellular rejuvenation therapies to reverse and prevent aging diseases. The company is focused on targeting the biology of aging, which is the biggest risk factor for most chronic diseases. They are developing a novel partial epigenetic reprogramming platform that targets a key underlying mechanism of aging to prevent and reverse age-related diseases with significant unmet need to extend healthy human lifespan. This approach holds the promise of treating many of the most debilitating and chronic diseases. The platform builds on innovative science from world-leading researchers to partially reprogram the epigenome of aged and injured cells to restore cellular function to a younger state. This is a B2B model.

Website: lifebiosciences.com
Social
Email ID: *****@lifebiosciences.com
Part Of

Key Metrics

Founded Year

2017

Location

Boston, United States

Stage

Series D

Total Funding

$261M in 9 rounds

Latest Funding Round

Series D, Apr 08, 2026, $*****

Investors

Alpha Wave Global & 14 more

Ranked

1^st among 10 active competitors

Employee Count

10 - 49 as on Mar 01, 2026

Investment & Acquisitions

Lua

Similar Companies

Retro & 10 more

View Life Biosciences' full profile

Life Biosciences is associated with 2 legal entities given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
Life Biosciences Inc. CIN: 6830463 , United States, Active	May 11, 2023	-	-	-
LIFE BIOSCIENCES LLC CIN: 821308372 , United States, Active	Jul 11, 2017	-	13 (As on Dec 31, 2024)	-

Life Biosciences has raised a total funding of $261M over 9 rounds. Its first funding round was on Jan 01, 2017. Life Biosciences has 15 institutional investors.

Here is the list of recent funding rounds of Life Biosciences:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Apr 08, 2026	8039614	Series D	1615604	8272623	9767367	7631819
Nov 25, 2025	2241955	Series C	3834967	5901495	8671270	2995180
Jan 06, 2022	3717360	Series C	5635646	7544197	Alpha Wave Global	The Longevity Fund

Access funding benchmarks and valuations. Sign up today!

View details of Life Biosciences's funding rounds and investors

The founders of Life Biosciences is Tristan Edwards.

Here are the details of Life Biosciences' key team members:

Tristan Edwards: Co-Founder of Life Biosciences and founder of 1 other company.
Contact Info: 1 email address
Jerry McLaughlin: CEO of Life Biosciences.
Contact Info: 1 email address

View details of Life Biosciences's Founder profiles and Board Members

Life Biosciences' employee count trend

Life Biosciences has 10 - 49 employees as of Mar 26. Here is Life Biosciences's employee count trend over the years:

Employee count trend for Life Biosciences

Uncover Life Biosciences' growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Life Biosciences include Retro, Cambrian BioPharma and Rejuveron Life Sciences. Here is the list of Top 10 competitors of Life Biosciences, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Life Biosciences 2017, Boston (United States), Series D	Biotechnology pioneering cellular rejuvenation therapies to reverse and prevent aging diseases	$261M	Globalive Capital, LeFrak & 13 others	61/100
2nd	Retro 2020, Redwood City (United States), Series D	Developer of therapeutics targeting cellular mechanisms to treat aging diseases	$180M	-	57/100
3rd	Cambrian BioPharma 2019, Brooklyn (United States), Series C	Developer of therapeutics targeting biological mechanisms associated with human aging	$216M	Catalio Capital Management, Apeiron Investment Group ... & 20 others	53/100
4th	Rejuveron Life Sciences 2019, Baar (Switzerland), Series B	Developer of drugs for treating age related diseases	$76.3M	Catalio Capital Management, Apeiron Investment Group ... & 12 others	51/100
5th	Altos Labs 2021, Redwood City (United States), Funding Raised	Lab conducting research on cellular rejuvenation programming to restore cell health and resilience	-	Foresite Capital, General Catalyst & 3 others	47/100
6th	Calico Labs 2013, San Francisco (United States), Acquired	Pioneering research and technology to understand aging and develop interventions	-	2M Companies	43/100
7th	Klothea Bio 2024, Miami (United States), Series A	Developer of longevity therapeutics for the treatment of age-related diseases	$5.94M	-	30/100
8th	Gerologix 2018, Evans (United States), Funding Raised	Developer of therapies for age-related diseases	-	Georgia Research Alliance, HHS	20/100
9th	Vertical Longevity Pharmaceuticals 2024, Irvine (United States), Unfunded	Developer of a vaccine targeting atherosclerosis and systemic aging	-	-	16/100
10th	Centenara 2020, Unfunded	Developer of therapies targeting geriatric diseases to expand healthspan and longevity	-	-	16/100